Uni Eropa -
Latvi -
EMA (European Medicines Agency)
degarelix accord
accord healthcare s.l.u. - degarelix acetate - prostatas audzēji - citi hormonu antagonisti un tiem līdzīgas vielas - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
Latvia -
Latvi -
Zāļu valsts aģentūra
abiraterone olainfarm 250 mg tabletes
olainfarm, as, latvia - abirateroni acetas - tablete - 250 mg
Latvia -
Latvi -
Zāļu valsts aģentūra
abiraterone olainfarm 500 mg apvalkotās tabletes
olainfarm, as, latvia - abirateroni acetas - apvalkotā tablete - 500 mg